Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Helicobacter Pylori Treatment Could Minimise Gastric Cancer Risk
1
Mins
July 2024
Researchers have unveiled that Helicobacter pylori treatment may be beneficial for individuals with a high genetic risk to gastric cancer.
Read more
5
Mins
15th April 2016
Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy
GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…
4
Mins
15th April 2016
Immunotherapy with Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma
GENEVA, Switzerland, 14 April 2016: Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and…
3
Mins
12th April 2016
Heine H. Hansen Award Goes to Suresh Senan
Geneva, Switzerland, 11 April: The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC)…
7
Mins
18th March 2016
STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy
STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy
3
Mins
23rd February 2016
First Patients Enrolled and Dosed in the Pivotal Trial of Phase 3 of the Immunotherapy Tedopi® for Advanced Non-Small Cell Lung Cancer
Paris, February 22nd, 2016, 6:30pm – OSE Pharma SA (ISIN: FR0012127173; Mnémo: OSE), an immunooncology company with a specific immunotherapy…
1
Mins
19th February 2016
Introducing the European Medical Journal 1.1
United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.
2
Mins
10th February 2016
Smoking and Inactivity Lead to Alarming Rise in Heart Attacks among Young Indians
Chennai, India 10 February 2016: An increase in smoking and physical inactivity in young adults in India has led to an alarming rise in heart attacks…
1
Mins
16th December 2015
ESMO Asia 2015 Congress
LUGANO/SINGAPORE, 16 December 2015 – ESMO, the leading professional organisation for medical oncology, is pleased to announce the inaugural ESMO Asia…
Loading posts...
« Previous
1
…
26
27
28
29
30
…
32
Next »